URMC / Research / Health Research /Clinical Trials / Study Details

UBRS20152 / BTCRC BRE15-024 / O'Regan

Research Question:
Do the drugs Ribociclib and Bicalutamide help treat breast cancer?

Basic Study Information

Purpose:
This is an open label, multi-institutional, single arm phase II trial of ribociclib in combination with bicalutamide in advanced AR+ triple-negative breast cancer. No randomization or blinding is involved.

Location: University of Rochester Medical Center
Study Reference #: STUDY00006374

Lead Researcher (Principal Investigator)

Lead Researcher: Ruth O'Regan

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Research

UR Health Research